GSK PLC (GSK)
43.34
+0.78
(+1.82%)
USD |
NYSE |
May 02, 16:00
43.40
+0.06
(+0.13%)
After-Hours: 20:00
GSK Cash from Operations (TTM): 8.422B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 8.422B |
September 30, 2023 | 7.220B |
June 30, 2023 | 5.619B |
March 31, 2023 | 5.821B |
December 31, 2022 | 9.167B |
September 30, 2022 | 11.64B |
June 30, 2022 | 13.92B |
March 31, 2022 | 13.89B |
December 31, 2021 | 10.94B |
September 30, 2021 | 10.68B |
June 30, 2021 | 8.483B |
March 31, 2021 | 10.05B |
December 31, 2020 | 10.83B |
September 30, 2020 | 10.54B |
June 30, 2020 | 12.22B |
March 31, 2020 | 10.61B |
December 31, 2019 | 10.24B |
September 30, 2019 | 11.26B |
June 30, 2019 | 10.84B |
March 31, 2019 | 10.90B |
December 31, 2018 | 11.24B |
September 30, 2018 | 9.236B |
June 30, 2018 | 9.213B |
March 31, 2018 | 8.715B |
December 31, 2017 | 8.932B |
Date | Value |
---|---|
September 30, 2017 | 9.498B |
June 30, 2017 | 9.056B |
March 31, 2017 | 9.500B |
December 31, 2016 | 8.803B |
September 30, 2016 | 6.876B |
June 30, 2016 | 5.525B |
March 31, 2016 | 4.085B |
December 31, 2015 | 3.926B |
September 30, 2015 | 5.235B |
June 30, 2015 | 6.582B |
March 31, 2015 | 7.559B |
December 31, 2014 | 8.532B |
September 30, 2014 | 8.444B |
June 30, 2014 | 9.605B |
March 31, 2014 | 10.90B |
December 31, 2013 | 11.30B |
September 30, 2013 | 10.85B |
June 30, 2013 | 7.124B |
March 31, 2013 | 7.280B |
December 31, 2012 | 6.933B |
September 30, 2012 | 7.300B |
June 30, 2012 | 10.66B |
March 31, 2012 | 10.03B |
December 31, 2011 | 10.02B |
September 30, 2011 | 8.827B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
5.619B
Minimum
Jun 2023
13.92B
Maximum
Jun 2022
10.13B
Average
10.61B
Median
Mar 2020
Cash from Operations (TTM) Benchmarks
AstraZeneca PLC | 9.698B |
Novo Nordisk A/S | 15.81B |
Pfizer Inc | 8.70B |
Sanofi SA | -- |
Moderna Inc | -3.118B |